Cellectar Adds Two to Board
Cellectar Biosciences added Douglas Swirsky and Frederick Driscoll to its board of directors, the company announced recently. Swirsky is the president and CEO of GenVec and has worked at Stifel Nicolaus…
Category Archives: Biotech
Lucigen Partners With Illumina
Lucigen announced recently it has partnered with Illumina to be the sole distributor of the entire Epicentre Technologies product line. Terms of the deal were not disclosed. The product line…
Cologuard Included in Star Ratings
The Centers for Medicare and Medicaid Services (CMS) is including Exact Sciences’ Cologuard in the 2018 Medicare Advantage Star Ratings program, the company announced recently. “We are pleased that Cologuard has…
Cellectar to Begin Phase II Trial
Cellectar Biosciences announced today its initiation of a Phase II clinical study of CLR 131 in patients with multiple myeloma and other hemotologic malignancies. According to a release, the study…
MVI Expands Clinical Trial
Madison Vaccines Incorporated’s clinical trial for metastatic prostate cancer is expanding to the University of Washington, its third site, the company announced recently. According to a release, MVI-118 is being explored for…
Cellectar Earns Japanese Patent
Cellectar Biosciences announced today the Japanese Patent Office has granted a composition of matter patent for its optical imaging phospholipid drug conjugates (PDCs), CLR 1501 and CLR 1502. “This patent…
Cellectar, WARF Reach License Agreement
Cellectar Biosciences and the Wisconsin Alumni Research Foundation announced it new license agreement for intellectual property rights covering the method of use for the company’s compound, CLR 131, in multiple…
Exact Sciences Study Shows Promise
A study by Exact Sciences and Mayo Clinic shows promise of a new blood-based lung cancer test, the organizations announced recently. “These results reveal an opportunity to detect lung cancer from…
Invenra to Collaborate with QIMR
Invenra has teamed up with Australian biomedical research and development center QIMR Berghofer Medical Research Institute to identify and characterize a panel of fully human therapeutic monoclonal antibodies against a novel…
SHINE Adds Board Member
SHINE Medical Technologies added Gregory OD Smith to its board of directors, the company announced recently. Smith has experience in the nuclear industry, having worked at Urenco, Louisiana Energy Services…
